$BYON insiders have traded $BYON stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales. Here’s a ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

SOFIA, BULGARIA / ACCESS Newswire / March 7, 2025 / The memecoin market has proven that virality and community engagement can turn simple tokens into global sensations. But while most memecoins ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats. Trump ...

Beyond (BYON) came out with a quarterly loss of $0.91 per share versus the Zacks Consensus Estimate of a loss of $0.74. This compares to loss of $1.22 per share a year ago. These figures are ...

Beyond Inc (NYSE:BYON) achieved a gross margin of 23% in Q4, surpassing their target of 21.5%, indicating effective cost management and pricing strategies. The company successfully reduced SG&A ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Ladies and gentlemen, thank you for standing by and welcome. At this time, all participants are in a listen-only mode. Following the presentation, there will be a question-and-answer session ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

Piper Sandler analyst Peter Keith maintained a Hold rating on Beyond Inc (BYON – Research Report) today and set a price target of $8.00. The company’s shares closed yesterday at $6.92.

Shares of BYON opened at $5.53 on Wednesday. The firm has a market capitalization of $294.10 million, a P/E ratio of -0.75 and a beta of 3.91. Beyond has a 12-month low of $4.45 and a 12-month ...